seems the executive teams for Biogen and Zosano have been meeting a lot as of late..
backfilling that empty pipeline.
apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal.
Being scooped up...
http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab.
Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than...
anonymous
Thread
amgen
eli lilly
fda
lawsuit
migraine
novartis
patent
pfizer
teva